Areata-Like Lupus as a Clinical Manifestation of Cutaneous Lupus Erythematosus.
Alopecia areata
Areata-like lupus
Cutaneous lupus erythematosus
Exclamation mark hair
Tapering hair
Journal
Skin appendage disorders
ISSN: 2296-9195
Titre abrégé: Skin Appendage Disord
Pays: Switzerland
ID NLM: 101670617
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
27
06
2021
accepted:
09
12
2021
entrez:
19
8
2022
pubmed:
20
8
2022
medline:
20
8
2022
Statut:
ppublish
Résumé
Lupus erythematosus (LE) is a chronic autoimmune disease that frequently causes hair loss and scalp lesions. Hair loss can be scarring and nonscarring, diffuse, or patchy. The nonscarring patchy alopecia is usually related to systemic LE (SLE) and may simulate alopecia areata (AA), reason why it is named areata-like lupus. Our case was diagnosed with areata-like lupus but did not meet criteria for SLE. A 63-year-old woman presented with irregular nonscarring patchy alopecia in the temporal and frontoparietal scalp. Trichoscopy showed exclamation mark hairs, vellus hairs, and sparse yellow dots. Histology revealed epidermal vacuolar interface dermatitis, lymphohistiocytic infiltrate around the bulbs of anagen follicles, and eccrine glands. Direct immunofluorescence showed deposits of C3, IgA, and IgG in the basement membrane zone. Patients with cutaneous LE can also manifest as nonscarring patchy alopecia that is clinically similar to AA, despite the absence of systemic manifestations. Areata-like lupus is secondary to the lupus autoimmune infiltrate that affects the skin including the hair follicles. Trichoscopy, histology, and direct immunofluorescence are important to differentiate this form of alopecia from AA, which is believed to have a higher incidence in lupus patients.
Identifiants
pubmed: 35983473
doi: 10.1159/000521549
pii: sad-0008-0322
pmc: PMC9275007
doi:
Types de publication
Case Reports
Langues
eng
Pagination
322-327Informations de copyright
Copyright © 2022 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors of this manuscript have no conflicts of interest, and there was no support or financial involvement for this publication. It is important to indicate that Dr. Romiti, one of the authors, is a member of the Editorial Board of “Skin Appendage Disorders.”
Références
J Am Acad Dermatol. 2016 Dec;75(6):1267-1268
pubmed: 27846956
Am J Clin Dermatol. 2018 Oct;19(5):679-694
pubmed: 29948959
J Am Acad Dermatol. 1981 Apr;4(4):471-5
pubmed: 7229150
Lupus Sci Med. 2018 Oct 25;5(1):e000291
pubmed: 30397497
J Cutan Pathol. 1995 Apr;22(2):97-114
pubmed: 7560359
Clin Dermatol. 2006 Sep-Oct;24(5):348-62
pubmed: 16966017
J Dermatol. 2018 Jun;45(6):692-700
pubmed: 29569271
J Autoimmun. 2019 Mar;98:74-85
pubmed: 30558963
Arch Dermatol. 1992 Mar;128(3):368-71
pubmed: 1550369
Dermatol Pract Concept. 2017 Jul 31;7(3):55-59
pubmed: 29085722
Australas J Dermatol. 2013 May;54(2):129-32
pubmed: 22985201
Pediatr Dermatol. 1993 Mar;10(1):29-31
pubmed: 8493162
Int J Trichology. 2014 Apr;6(2):54-62
pubmed: 25191038
J Autoimmun. 2014 Feb-Mar;48-49:10-3
pubmed: 24461385
Int J Dermatol. 2017 Feb;56(2):161-165
pubmed: 28074524
Lupus. 2013 Dec;22(14):1439-45
pubmed: 24132518
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Br J Dermatol. 2018 Nov;179(5):1033-1048
pubmed: 29791718